October 26, 2014 5:43 AM ET

Pharmaceuticals

Company Overview of Vaxin Inc.

Company Overview

Vaxin Inc. develops vaccines and other biological products to control infectious diseases. It provides vaccines to protect people against influenza and anthrax infection using proprietary technologies for intranasal delivery. The company provides AdVAV anthrax vaccine; NasoVAX pre-pandemic influenza (bird-flu) vaccine, a non-replicating adenovirus encoding the hemagglutinin (HA) protein from the influenza virus; and NasoVAX seasonal influenza vaccine. It also develops vaccines for animal health, including vaccines to protect poultry and swine, and a vaccine to sterilize cats and dogs. Vaxin Inc. was formerly known as ImmuneFocus Corporation. The company was founded in 1997 and is based in Ga...

19 Firstfield Road

Suite 200

Gaithersburg, MD 20878

United States

Founded in 1997

Phone:

240-654-1450

Fax:

855-557-1369

Key Executives for Vaxin Inc.

Chief Executive Officer
Chief Financial Officer
Corporate Counsel and Secretary
Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Synthon Pharmaceuticals, Inc. United States
PureTek Corporation United States
OncoHoldings, Inc. United States
ChanRx Corp. United States
Vitalabs, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vaxin Inc., please visit www.vaxin.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.